Ticker Symbol: ANTX
AN2 Therapeutics Inc
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001880438
Company Profile
an2 therapeutics, inc. is a california-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. an2 is a mission-driven company, with a vision for humanity to be free from the threat of infectious diseases by addressing the urgent need for new treatments that can save lives across the globe. founded by a small team of biopharmaceutical industry leaders with a passion for global health and experience in infectious disease drug r&d, we strive to bring patients treatments that will restore their health and enable them to live productive lives.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: N/A
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 20, 2023 03:30 PM EST
Previous Close: $14.99
Change:
$0.44
(
3.02%)
Days Range: $14.30 - $15.22
Beta: 0.30
52wk. High: $17.29
52wk. Low: $4.87
Ytd. Change 60.32%
50 Day Moving Average: $14.84
200 Day Moving Average: $9.86
Shares Outstanding: 21928452
Valuation
Market Cap: 32.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A